AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Delayed viral load decrease of Omicron variant compared to Delta variant in 2 nasopharyngeal samples from COVID-19 patients.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HBcrAg tightly correlates with elevated HDV replicative activity and with enhanced liver inflammation and damage: role of HBcrAg as a biomarker of liver disease progression in the setting of HDV co-infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancerView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Virological characterization of treatment failures and retreatment outcomes in patients infected with “unusual” HCV genotype 1 subtypesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Interpretation of the T66I and G118R mutations in integrase in HIV-2View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Major protease resistance in West African HIV-1 subtypes is associated with novel protease mutations and accelerated gag evolution during second-line ARTView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Evaluation of the virological efficacy of switching to dolutegravir-based tritherapy in patients followed under real-life conditions in Abidjan, Côte d'IvoireView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Resistance analysis of pre- treatment NS3 and NS5A variants in HCV genotype 1a, 1b and 3a infected patients in CroatiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Using social media to improve follow-up and routine checks on newly diagnosed young people living with HIV and their adherence to Antiretroviral TherapyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Changes in the HIV-1 3'- polypurine tract in patients failing dolutegravir in BrazilView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Analysis of mutational history of multi-drug resistant genotypes with a mutagenetic tree modelView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Predictors of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settingsView Abstract
